These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17524034)

  • 1. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism.
    Vantyghem MC; Faivre-Defrance F; Marcelli-Tourvieille S; Fermon C; Evrard A; Bourdelle-Hego MF; Vigouroux C; Defebvre L; Delemer B; Wemeau JL
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):247-9. PubMed ID: 17524034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
    Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
    Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.
    Vantyghem MC; Vincent-Desplanques D; Defrance-Faivre F; Capeau J; Fermon C; Valat AS; Lascols O; Hecart AC; Pigny P; Delemer B; Vigouroux C; Wemeau JL
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2223-9. PubMed ID: 18364375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
    Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation.
    Araújo-Vilar D; Loidi L; Domínguez F; Cabezas-Cerrato J
    Horm Metab Res; 2003 Jan; 35(1):29-35. PubMed ID: 12669268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-type lamin-linked lipodystrophies.
    Vigouroux C; Capeau J
    Novartis Found Symp; 2005; 264():166-77; discussion 177-82, 227-30. PubMed ID: 15773753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retinol acid receptor B gene is hypermethylated in patients with familial partial lipodystrophy.
    Cortese R; Eckhardt F; Volleth M; Wehnert M; Koelsch U; Wieacker P; Brune T
    J Mol Endocrinol; 2007 Jun; 38(6):663-71. PubMed ID: 17556535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
    Caron M; Auclair M; Donadille B; Béréziat V; Guerci B; Laville M; Narbonne H; Bodemer C; Lascols O; Capeau J; Vigouroux C
    Cell Death Differ; 2007 Oct; 14(10):1759-67. PubMed ID: 17612587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA.
    Thong KM; Xu Y; Cook J; Takou A; Wagner B; Kawar B; Ong AC
    Nephron Clin Pract; 2013; 124(1-2):31-7. PubMed ID: 24080738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.
    Briand N; Guénantin AC; Jeziorowska D; Shah A; Mantecon M; Capel E; Garcia M; Oldenburg A; Paulsen J; Hulot JS; Vigouroux C; Collas P
    Hum Mol Genet; 2018 Apr; 27(8):1447-1459. PubMed ID: 29438482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).
    Lanktree M; Cao H; Rabkin SW; Hanna A; Hegele RA
    Clin Genet; 2007 Feb; 71(2):183-6. PubMed ID: 17250669
    [No Abstract]   [Full Text] [Related]  

  • 13. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.
    Vadrot N; Duband-Goulet I; Cabet E; Attanda W; Barateau A; Vicart P; Gerbal F; Briand N; Vigouroux C; Oldenburg AR; Lund EG; Collas P; Buendia B
    Hum Mol Genet; 2015 Apr; 24(7):2096-109. PubMed ID: 25524705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy.
    Lüdtke A; Genschel J; Brabant G; Bauditz J; Taupitz M; Koch M; Wermke W; Worman HJ; Schmidt HH
    Am J Gastroenterol; 2005 Oct; 100(10):2218-24. PubMed ID: 16181372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
    Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.
    Akinci B; Onay H; Demir T; Savas-Erdeve Ş; Gen R; Simsir IY; Keskin FE; Erturk MS; Uzum AK; Yaylali GF; Ozdemir NK; Atik T; Ozen S; Yurekli BS; Apaydin T; Altay C; Akinci G; Demir L; Comlekci A; Secil M; Oral EA
    Metabolism; 2017 Jul; 72():109-119. PubMed ID: 28641778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations.
    Araújo-Vilar D; Victoria B; González-Méndez B; Barreiro F; Fernández-Rodríguez B; Cereijo R; Gallego-Escuredo JM; Villarroya F; Pañeda-Menéndez A
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):816-24. PubMed ID: 21883346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.
    Hegele RA
    Mol Genet Metab; 2000 Dec; 71(4):539-44. PubMed ID: 11136544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
    Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
    Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.